Podcasts about Pharmaceutical industry

In this episode of Alter Everything, we chat with Patrick Leung, CTO of Faro Health, about the innovative ways his company is using generative AI to revolutionize the clinical trial process. They discuss handling unstructured data, insights generated by AI to optimize trials, and significant cost savings in the pharmaceutical space! Not sure what a clinical trial is? Fear not! Patrick explains the structure of clinical trials, Faro Health's AI-driven enhancements in medical writing, and the importance of data extraction and analysis.Panelists: Patrick Leung, Chief Technical Officer @ Faro Health - LinkedInMegan Bowers, Sr. Content Manager @ Alteryx - @MeganBowers, LinkedInShow notes: Faro HealthAlteryx's Generative AI for AnalyticsClinicaltrials.gov Interested in sharing your feedback with the Alter Everything team? Take our feedback survey here!This episode was produced by Megan Bowers, Mike Cusic, and Matt Rotundo. Special thanks to Andy Uttley for the theme music and Mike Cusic for the for our album artwork.

Season 10 is on the horizon, but before we release our first episode, why not tune in to some of Isabel and Jade's favourite moments from season 9?  From leadership insights from top CEOs to navigating setbacks in R&D, there's plenty to discover in this season's batch of GOLD Medal Moments.   As well as the EMJ GOLD team, you'll hear from four former guests:  Charl van Zyl, CEO, Lundbeck Pharmaceuticals  Dr Dennise Broderick, President and Managing Director, Galen Pharma  Rebecca Vermeulen, recipient of the Healthcare Businesswomen's Association (HBA) STAR award for 2025  Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer Ingelheim 

Analyzing Trump's plan to roll back soaring drug prices for Americans; Sports bras eliminate bounce but may take a toll on women's backs; RFK Jr. targets the chemicals in our food; Do Americans really eat more animal protein than any other of the world's nations? Causes and treatments for pulmonary hypertension.

How many times have you been told your heavy periods, low libido, or mood swings are “just part of being a woman”? Or handed birth control as the only option, without anyone actually explaining why your body feels off?If you're nodding along, this episode is a must-listen. Today, I'm joined by Dr. Jolene Brighten—a board-certified naturopathic endocrinologist, menopause specialist, and author of Beyond the Pill and Is This Normal?—and she's here to drop some serious truth bombs about women's health.We're breaking down the hormone myths that keep women confused and stuck, how to actually know if you have PCOS or endometriosis (even if you're on the pill), and why your sex drive, sleep, and strength training are all connected.Get ready for real talk, science-backed advice, and the permission you've been waiting for to finally understand (and trust) your body.​​Dr. Jolene Brighten is a board-certified naturopathic endocrinologist and best-selling author known for her expertise in women's health, hormones, and sexual wellness. Dr. Brighton is also the founder of Dr. Brighten Essentials.Trust me, you won't want to miss it! We Also Discuss:(00:31) The Truth About Women's Health – Dr. Jolene Brighten's No-BS Approach(13:13) Why Women's Health is Still Ignored: The Real Challenges(20:27) Endometriosis & PCOS: What You're Not Hearing from Doctors(29:52) Breaking the Silence: How to Normalize Women's Health Conversations(35:01) How Stress Kills Your Sex Drive: The Truth About Hormonal Balance(46:15) The Hidden Connection Between Hormones & Your Sexual Desire – Explained(58:02) Perimenopause Isn't the End: How to Thrive in Your 40s and Beyond(01:04:45) Eating, Sleeping, and Strength Training: The Key to Hormonal HarmonyThank You to Our Sponsors:Broads App – Get structured, progressive training and a powerhouse community to keep you strong, consistent, and unstoppable. Join at broads.app and use code PODCAST for 20% off your first month!Find more from Tara: Website: https://www.taralaferrara.com/Instagram: @taralaferrara @broads.podcast @broads.appYoutube: Tara LaFerraraTiktok: @taralaferraraFind more from Dr. Jolene BrightenWebsite: drbrighten.comInstagram: @drjolenebrightenTikTok: @drjolenebrightenYouTube: Dr. Jolene BrightenThe Perimenopause Weight Loss Action Plan: https://drbrighten.com/plan/

3 Big Stories: -Trump Administration has Success on International Stage -An American Pope Impossible No More, Chicago Native Cardinal Robert Prevost Elected and Announced as Pope Leo XIV -Trump Executive Order Demands Pharmaceutical Industry Slash Drug Prices

The Dublin-based biotech company Nuritas, which uses AI to identify supplements and new drugs by developing bioactive peptides, is changing the pharmaceutical industry.Their CEO, Nora Khaldi joins Kieran in Boston to discuss.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.President Donald Trump has issued an executive order to expedite the timeline for building new facilities in the US while increasing inspections on foreign plants. Despite a drop in venture capital fundraising in the first quarter of the year, large investments are still being made in the pharmaceutical industry. Companies like BMS are investing billions in US manufacturing despite potential tariffs. Vertex has seen success with their non-opioid pain drug launch and biopharma venture capital fundraising has declined, but median deal sizes remain high. Lotte Biologics offers specialized ADC manufacturing services in Syracuse, NY. Other news includes Lilly's ALS pipeline expansion, states suing to block HHS cuts, and layoffs at PTC despite a Phase II win. Thank you for tuning in to today's episode of Pharma and Biotech daily. Let's dive into the latest updates from the industry.

In this episode of Tickers, Dr. Matthew Preston & Dr. Thaon Simms analyze Indies Pharma (INDIES) and its potential to reach $5 per share!

Professor Jon Jureidini is a child psychiatrist who leads the Critical and Ethical Mental Health research group at Adelaide University in Australia. His forensic deconstruction of industry-sponsored clinical trials has exposed how pharmaceutical companies manipulate data, employ ghostwriters, and cultivate academic figureheads to create an illusion of scientific consensus around their products. Prof. Jureidini has revealed how medications prescribed to our most vulnerable populations—children and adolescents—gained approval based on studies that were fundamentally misrepresented in the scientific literature. In his groundbreaking book, 'The Illusion of Evidence-Based Medicine: Exposing the crisis of credibility in clinical research,' co-authored with Leemon McHenry, he systematically demonstrates how commercial interests have hijacked the evidence base that clinicians rely on, compromising patient care in the process. His work raises profound questions about the integrity of published research and challenges us to reconsider the foundations of modern medicine. Jureidini reveals shocking findings about the landmark 'Treatment of Adolescent Depression Study (TADS) study that's been used to justify prescribing antidepressants to teenagers—despite evidence showing a five-fold increase in suicidal events. With nearly 20% of adolescent girls now taking SSRIs, this conversation exposes the profit-driven deception that puts millions of developing brains at risk while pharmaceutical companies continue to thrive on what Jureidini calls "the illusion of evidence-based medicineChapters00:00 Introduction to the Crisis in Psychiatry02:20 The Illusion of Evidence-Based Medicine04:34 The TADS Study: A Closer Look10:47 Evaluating the TADS Study's Findings14:22 The Ethics of Informed Consent26:28 Risks and Alternatives in Treatment32:59 The Controversy of Antidepressant Prescriptions35:46 Ethical Concerns in Pharmaceutical Practices40:29 The Impact of Clinical Trials on Drug Approval47:08 Challenges in Psychiatric Research and Publication50:29 Restoring Trust in Scientific Integrity58:20 A Shift Towards Social Determinants of Mental Health RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman welcome Dr. Paul Offit to discuss the evolution of COVID-19 from pandemic to endemic status, the challenges of misinformation and public health messaging, and the importance of rebuilding trust in science. The scientists explore the challenges of effective public health communication amid widespread misinformation, examining how trust in scientific institutions has been affected. Dr. Offit shares insights on mRNA vaccine technology and addresses the evidence surrounding SARS-CoV-2's origins, emphasizing the scientific consensus supporting natural emergence rather than laboratory origin. The conversation also tackles the persistent vaccine-autism controversy, with Dr. Offit debunking common myths while providing context on autism research. Throughout the episode, the experts highlight the complex relationship between pharmaceutical development, public health, and the critical importance of evidence-based approaches to combat misinformation. (00:00) Intro (02:22) Understanding the Transition from Pandemic to Endemic (05:18) Misinformation and Public Health Messaging (10:21) Rebuilding Trust in Science (12:29) The Role of mRNA Technology in Vaccines (18:20) Comparing COVID-19 and Influenza (24:18) The Origins of SARS-CoV-2 (26:49) Investigating the Origins of SARS-CoV-2 (32:11) The Autism and Vaccine Controversy (37:25) Pharmaceutical Industry and Vaccine Trust (43:20) Natural Immunity vs. Vaccination (46:12) The Current State of Public Health and Vaccination https://www.paul-offit.com/ https://pauloffit.substack.com/ Dr. Offit's book: Tell Me When It's Over: An Insider's Guide to Deciphering Covid Myths and Navigating Our Post-Pandemic World https://amzn.to/3YSCDwq ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of "Getting There The Podcast," host Brogan delves into a deeply personal and eye-opening discussion following her recent interviews with Dr. Aseem Malhotra, a cardiologist and whistleblower, and Dr. Joel Gator-Warsh, a paediatrician with an integrative approach to medicine. Brogan reflects on the alarming realities of the pharmaceutical industry, which, despite being valued at over $1.5 trillion globally, has not improved public health outcomes. She highlights the shocking statistic that statins, commonly prescribed for heart health, only benefit 1 in 100 patients, yet are heavily marketed to the public. Brogan emphasises the industry's profit-driven motives, revealing that pharmaceutical companies prioritise shareholder returns over patient care. This episode serves as a wake-up call about the influence of big pharma on health and medicine, urging listeners to reconsider the information they receive about treatments and medications.

Capitalism is an illness: it's killing our planet, and by extension, us. Economic instability and environmental concerns are symptoms that can only be cured by redefining prosperity in terms of health and wellbeing, so that we can create sustainable, equitable societies. In his new book, The Care Economy, returning guest Tim Jackson dives into historical and systemic reasons behind our current economic challenges and shares personal experiences that highlight the importance of systemic change in healthcare and beyond. He shares insights from his book around the philosophical and practical implications of fostering a balanced, care-oriented economic model - and how it might just save the world.Image credit: Fernando Manoso-Borgas Featured guests:Tim Jackson, ecological economist, radio dramatist, Director of the Centre for the Understanding of Sustainable Prosperity (CUSP), and author.Links: Prosperity without Growth - Tim JacksonPhysiologist Walter Cannon - National Library of MedicineAneurin Bevin, architect of the NHS - BBCCurrent epidemic of chronic disease - CDCEcological Economics - The International Society for Ecological EconomicsThe Flexner Report - National Library of MedicineCities as Urban Laboratories - Cities 1.5If you want to learn more about the Journal of City Climate Policy and Economy, please visit our website: https://jccpe.utpjournals.press/ Cities 1.5 is produced by the University of Toronto Press and Cities 1.5 is supported by C40 Cities and the C40 Centre for City Climate Policy and Economy. You can sign up to the Centre newsletter here. https://thecentre.substack.com/ Our executive producers are Calli Elipoulos and Peggy Whitfield. Produced by Jess Schmidt: https://jessdoespodcasting.com/ Edited by Morgane Chambrin: https://www.morganechambrin.com/ Music is by Lorna Gilfedder: https://origamipodcastservices.com/

In this episode, Tudor and Tim Murtaugh discuss the implications of the Biden pill penalty, a provision in the Inflation Reduction Act that negatively impacts the pharmaceutical industry and healthcare costs. They explore how this legislation discourages the development of cheaper, more effective medications, leading to increased healthcare costs and lost life years. The conversation also touches on the role of China in pharmaceutical development, the unintended consequences of legislation, and the importance of intellectual property laws in protecting creators. The Tudor Dixon Podcast is part of the CLay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.comSee omnystudio.com/listener for privacy information.

Show Notes  Welcome friends to the Next Chapter with Charlie. Our fascinating guest today totally reinvented her life around 50 years old. From successful a successful life of 25 years in the Pharmaceutical Industry, Kavita realized her once fulfilling business life no longer offer the internal meaning she began longing for.  Instead of just living with dissatisfaction she searched and found a new way of life derived from the Japanese concept of Ikagi—"a way of being” that promotes meaning, purpose, and passion. Her story of discovery and reinvention guides all of us to reconsider what it means to live a most important life.  LINKS Please check out Kavita's website HERE.  You can find Kavita's podcast The Midlife Reinvention Podcast HERE.      

Iñaki m'a expliqué comment il a accéléré sa carrière. Comment il a pu être meilleur et plus performant. Et sa solution tient en un mot :L'authenticité.Iñaki de Rezola est le DG Advanced Accelerator Applications, une pépite rachetée en 2018 par Novartis.C'est un acteur historique dans les radioligands diagnostiques et thérapeutiques, une technologie ultra prometteuse en oncologie.Iñaki va nous parler d'une aventure professionnelle où ses capacités humaines sont déterminantes. Il nous parle de :- La technologie fascinante des radioligands- Gérer les incertitudes dans un monde qui se transforme- Vivre avec un ADN particulier : l'urgence de quelques heures pour soigner les patientsMais il va aller plus loin et nous expliquer comment il a réussi à faire les choses avec authenticité. Iñaki nous parle de l'urgence d'être soi. Comment le personnel change la trajectoire des performances professionnelles. C'est une histoire sur les relations humaines qui construisent le succès dans la vie.J'adore cet épisode, il est unique de sincérité. Et je remercie infiniment Iñaki pour avoir eu le courage de cet échange.Si vous voulez une vraie discussion sur l'authenticité, cet épisode est fait pour vous ! -Notes et références de l'épisodeLien :  Adacap : https://www.adacap.com/ Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

A panel discussion of a Presidential Advisory from the American Heart Association that outlines the importance of funding for scientific research and the need for a robust National Institutes of Health. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington INCLUDE URLS and full titles for some of the pertinent studies cited. You may also like: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association https://doi.org/10.1161/cir.0000000000001319 The Role of Public-Sector Research in the Discovery of Drugs and Vaccines." https://www.nejm.org/doi/full/10.1056/NEJMsa1008268 Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019 https://pubmed.ncbi.nlm.nih.gov/37115539/ Hear John Mandrola, MD's summary and perspective on the top cardiology news each week on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

Dr. Hoffmabn continues his conversation with investigative reporter Gardiner Harris, author of “No More Tears: The Dark Secrets of Johnson and Johnson.” 

Former pharma reporter for the New York Times and the Wall Street Journal, investigative reporter Gardiner Harris, discusses his new book “No More Tears: The Dark Secrets of Johnson and Johnson.” It details the unethical practices and numerous scandals that have plagued Johnson & Johnson over the decades, including the asbestos contamination in baby powder, the misuse of the antipsychotic drug Risperdal, the dangerous outcomes of vaginal mesh implants, and the controversial development and deployment of their COVID-19 vaccine. Harris provides a comprehensive overview of the corporate malfeasance within the pharmaceutical giant, shedding light on the regulatory failures and systemic corruption that have allowed these issues to persist.

Incyte Corporation v. Sun Pharmaceutical Industries, Ltd.

In this episode, Tudor interviews investigative journalist Gardiner Harris about his new book, 'No More Tears: The Dark Secrets of Johnson & Johnson.' The conversation delves into the shocking revelations about the pharmaceutical giant's unethical practices, including the marketing of harmful products, the manipulation of regulatory agencies, and the impact of their actions on public health. Harris shares insights from his five-year investigation, highlighting the need for accountability in the healthcare industry and the importance of informed consumer choices. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.com Follow Gardiner Harris on X Buy No More Tears: The Dark Secrets of Johnson & Johnson HERE #Johnson & #Johnson #healthcare #pharmaceuticalindustry #ethics #investigativejournalism #publichealth #medicaldevices #COVID19 #marketing #regulationSee omnystudio.com/listener for privacy information.

In this episode of The Brand Called You, Dr. Tia Warrick, an AI and clinical research expert, shares insights on revolutionizing healthcare efficiency, bridging workforce gaps, and the future of pharmaceutical careers. Discover how AI is reshaping the industry and making clinical trials more effective.00:35- About Dr. Tia WarrickTia is a public health director, a clinical researcher, and an AI expert. She's the CEO of Lesous Consulting, and she's the author of a book titled Burst the Bubble: A Look Into Careers in the Pharmaceutical Industry.

Slovakia, dubbed Europe's Detroit, might be harshly hit by US tariffs. Economy Minister Denisa Saková has warned that Slovakia would definitely be “among the top three” most affected countries in the EU. Martin Šuster, member of the Council for Budget Responsibility, Alexander Matušek, President of the Association of the Automotive Industry of the Slovak Republic, and Roman Karlubík, President of the Association of the Chemical and Pharmaceutical Industry of the Slovak Republic, spoke about the possible impact on Slovakia. Culture tips for foreigners living in or visiting Slovakia invite to music, visual art and traditional Easter crafts.

Slovakia, dubbed Europe's Detroit, might be harshly hit by US tariffs. Economy Minister Denisa Saková has warned that Slovakia would definitely be “among the top three” most affected countries in the EU. Martin Šuster, member of the Council for Budget Responsibility, Alexander Matušek, President of the Association of the Automotive Industry of the Slovak Republic, and Roman Karlubík, President of the Association of the Chemical and Pharmaceutical Industry of the Slovak Republic, spoke about the possible impact on Slovakia. Culture tips for foreigners living in or visiting Slovakia invite to music, visual art and traditional Easter crafts.

Dr. Lufkin exposes the influence of the pharmaceutical industry on medical education and encourages listeners to take control of their health through informed choices about nutrition, exercise, sleep, and stress management. Learn why early health monitoring and metabolic awareness are key to preventing disease and living a longer, healthier life.In this episode of Amazing People Amazing Things, Dr. Robert Lufkin dives into the growing epidemic of chronic diseases and why Western medicine often falls short in addressing them.visit: www.RobertLufkinMD.comvisit: www.AmazingPeopleAmazingThings.com

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sanofi has committed up to $1.9 billion to acquire Dren Bio's bispecific antibody for autoimmune disease, adding to its investments in the immunology portfolio. The deal comes after the tragic death of a patient who had taken the gene therapy Elevydys, prompting the Duchenne patient community to vow to push on. Paratek Pharmaceuticals has acquired Optinose for up to $330 million, while Senate Democrats demand the return of fired CDC staff. Sino Biological has developed recombinant antigens for the 2025-2026 influenza vaccine strains, and Purdue has filed for bankruptcy to support a $7.4 billion opioid settlement. Doctors continue to rally behind vaccines amidst doubts and misinformation, and Novartis' intrathecal Zolgensma has shown effectiveness in older children. TC Biopharm and Cargo have enacted steep workforce reductions. Pharmaceutical companies are also preparing for upcoming events, including webinars on AI regulation and drug development. Job opportunities in the pharmaceutical industry are available at companies like Takeda, Eli Lilly and Company, and Novo Nordisk.

Laura Delano is the author of “Unshrunk: A Story of Psychiatric Treatment Resistance”. Her story serves as a powerful lesson, illuminating the all too familiar path toward iatrogenic harm that continues to affect patients within our mental healthcare system. She is the Executive Director of Inner Compass Initiative, a charitable organization that she founded to help people make more informed choices about psychiatric diagnoses, drugs, and drug withdrawal. She is a leading voice in the international movement of people who've left behind the medicalized & professionalized mental health industry to build something different. Laura works with individuals and families around the world seeking guidance and support for psychiatric drug withdrawal and life post-psychiatry.Laura Delano Website Inner Compass Initiative 00:00 The Allure of Simple Explanations02:53 The Awakening of Laura Delano05:51 The Journey into Psychiatry08:47 The Impact of Diagnosis12:04 The Role of Family and Society15:00 The Medicalization of Mental Health18:08 The Influence of Pharmaceutical Industry21:00 The Consequences of Early Diagnosis24:04 The Quest for True Healing35:25 The Ethics of Experimental Drugs36:09 Understanding Perspectives in Psychiatry39:32 The Role of Responsibility in Prescribing43:16 Navigating Personal Identity and Mental Health47:45 Desperation and the Path to Psychiatry52:42 Cultural Reflections on Mental Health56:01 The Value of Pain and Suffering01:09:52 The Confusion of Psychiatric Treatment01:12:45 The Flaws in the Therapy Industry01:17:15 The Challenge of Questioning Authority01:19:46 The Trap of Psychiatric Diagnosis01:22:29 The Power Dynamics in Psychiatry01:26:46 The Disembodiment and Exploitation of Human Nature01:30:37 The Need for Medical Freedom01:34:39 The Importance of Compassion in Psychiatry01:39:30 Reclaiming Embodiment and True Nature01:41:54 Navigating the Path to Recovery RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS

In the latest episode of The Top Line, Chris Hayden of Fierce Pharma sits down with Mary Lou Glotzbach, senior manager of drug delivery partnerships at Grand River Aseptic Manufacturing (GRAM). They explore the evolving landscape of biologics, the increasing importance of cold chain management, and how contract development and manufacturing organizations (CDMOs) are adapting to industry shifts. Glotzbach highlights a growing trend in biotech: transitioning patient treatments from infusion centers to home delivery. This shift demands innovative drug delivery solutions, including wearable devices and auto-injectors, capable of handling high-viscosity biologics. She also emphasizes the industry's push for smaller batch sizes due to the high cost and complexity of producing biologics, which challenges traditional manufacturing processes. Another key discussion point is the rising demand for transparency and early collaboration between pharmaceutical companies, CDMOs, and device manufacturers. Glotzbach notes that CDMOs are now being brought into the development process earlier than ever, allowing for better alignment on formulation, container design, and regulatory compliance. The conversation also touches on Annex 1 compliance and the need for standardization in primary containers like syringes and cartridges. Glotzbach envisions a future where standardized components streamline production, making drug development more efficient. For anyone interested in the intersection of biologics, manufacturing, and drug delivery innovation, this episode offers valuable insights into how GRAM is helping shape the future of the industry. Tune in to learn more about the latest advancements and challenges in aseptic manufacturing.See omnystudio.com/listener for privacy information.

How is Trump's executive order redefining the language permissible in scientific research, and what does it mean for academic freedom? Today, we examine the complexities surrounding scientific research under shifting political landscapes with Ivan Oransky, a seasoned medical journalist and co-founder of Retraction Watch. Oransky discusses the implications of President Trump's executive orders and how it has sent ripples throughout the scientific community, causing researchers to reconsider their work amidst existential uncertainties. Oransky explores the nuanced relationship between government funding and scientific inquiry. This episode unpacks the historical precedents of government involvement in research, tracing back to the 1940s, and examines the mounting challenges faced by scientists under the recent policy changes. Oransky provides a critical analysis of how such directives potentially stifle open inquiry and drive talented researchers away, ultimately impacting the future landscape of scientific discovery. In This Episode:Implications of Trump's executive orders on scientific researchHistorical context of government funding in scientific researchThe impact of political climates on scientific inquiry and transparencyChallenges of anticipatory obedience within research communitiesIvan Oransky's insights on sustaining open and rigorous scientific dialogue About Ivan:Ivan Oransky, MD, is the co-founder of Retraction Watch, the Editor in Chief of The Transmitter, and a Distinguished Journalist in Residence at New York University's Carter Journalism Institute, where he teaches medical journalism. He has held leadership positions at Medscape, MedPage Today, Reuters Health, Scientific American, and The Scientist. A former president of the Association of Health Care Journalists from 2017 to 2021, Oransky earned his bachelor's degree from Harvard and an MD from NYU School of Medicine. His contributions to biomedical communication have earned him accolades, including the John P. McGovern Award and commendation from the John Maddox Prize judges for his work at Retraction Watch. Read HXA's newsletter Free the Inquiry: https://heterodoxacademy.substack.com/Follow Ivan on X: https://x.com/ivanoransky  Follow Heterodox Academy on:Twitter: https://bit.ly/3Fax5DyFacebook: https://bit.ly/3PMYxfwLinkedIn: https://bit.ly/48IYeuJInstagram: https://bit.ly/46HKfUgSubstack: https://bit.ly/48IhjNF

A Super Bowl commercial for weight loss drugs causes an uproar; Adding a familiar amino acid to tuna reduces mercury content; Rethinking epidural shots for back pain; CV Sciences debuts innovative new CBD gummies, drinks. 

Dr. Peter Glidden shares his extensive clinical experience on how to address conditions like Alzheimer's and vertigo using naturopathic therapeutics. Learn about the monopolization of the medical market by the AMA and Big Pharma. #NaturopathicMedicine #BigPharma #HealthFreedom

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Gerit D. Mulder to the podcast!  Dr. Mulder gave Dr. Jensen an opportunity to join his practice at the Wound Healing Institute after residency, providing a tremendous foundation for future research that included the National Institutes of Health, and Department of Defense opportunities.  Dr. Mulder has a storied history in podiatric medical research in the wound care space.  He received his BS at University of Redlands; a masters degree from Cal State - San Bernadino, then received his DPM from the College of Podiatric Medicine. He received his PhD from Chulalongkorn University through University of California San Diego specializing in Biomedical Sciences/Stem Cells.  Gerit speaks 5 languages and has taught wound care, and implemented wound care programs around the world.  Tune in for a fabulous interview! Below is a brief history of Dr. Mulder's activities and qualifications: • Extensive expertise in the development, implementation and management of clinical trials, clinical operations and teams.  Experience as a lead Principal Investigator interacting with and guiding multicenter trials.  Direct interaction with the FDA, Pharmaceutical Industry and Academic Research Centers.  Focus on Inflammatory Diseases, Dermatology and Infectious Disease.  • Responsible for development and oversight than 120 clinical trials. • Supervised, educated, and guided research teams globally. • Developed project budgets, protocols, guidelines, and implementation plans for developing wound clinics. • Provided strategic and tactical input to the medical industry related to clinical trials with emphasis on Phase 1,2 and 3 studies.  • Created tissue and wound repair programs to increase product understanding to assist Emerging Markets. Additional Expertise and Affiliations Include: • Understanding of Regulatory Affairs. • International experience with monitoring and overseeing clinical trials. • Served as a national and international  • Provided input on new product development for novel disease states.  • Conversational skills in English, Spanish, Italian, French, and German • Extensive experience with KOLs and medical advisory boards. Physician at Christus St. Vincent Medical Center, Wound & Hyperbaric Center. December 2021 to current. • Provide advanced clinical care for chronic wounds of all etiologies including diabetic, venous, pressure, trauma and other wounds. • Direct wound and tissue repair and regeneration research Medical Research Consultant – Independent 2019 – current Clinical Tissue Repair and Regeneration Specialist – 2019-current • Consult internationally on Phase 1,2, and 3 clinical trials • Provide input for development and implementation of clinical trials and educational materials for health care providers related to phase 1, 2 and 3 studies as well as approved products. • Provide clinical care to patients with acute and chronic wounds of all etiologies Director, Professor of Surgery and Orthopedics University of California San Diego Medical Center, Wound Treatment and Research Center   April 1998- December 2013 •  Provided clinical and surgical care, conducted medical student, resident and staff education, oversaw clinical research.  Treated more than 3000 patients per year.  Published in peer reviewed medical journals and key presenter at medical conferences globally. • Oversaw research within my division of the Department of Trauma, with focus on tissue regeneration and repair, inflammatory and infectious related diseases and cell regeneration. June 1986-April 1998: President of WCI (Wound Consultants Inc., previously Wound Healing Institute)    WCI offered consulting services to the biotechnology and pharmaceutical industry related to clinical protocols and trials, implementation of related patient care, planning and managing medical education.  Advised on development of new products related to tissue regeneration and repair. Patient Care    Vice President of Marketing and Medical Affairs DermaRx  May 1995- March 1998 Vice President of Clinical and Regulatory Affairs Organogenesis, Inc.   May 1994-May 1995     Wound Clinic Director Veterans Administration Hospital Denver June 1983- Jne 1992 FDA Experience: • Participated as an advisor to the FDA and companies working with the FDA • Completed and submitted 510k for hydrogel, foam, and other wound treatment devices • Completed clinical section of PMA submission on Apligraf for Organogenesis • Consulted as wound care expert on panels for medical and pharmaceutical industry. • Chaired Human Subjects Committee in Denver for two years for a major IRB. • Interacted with FDA on Dermatology and Inflammatory Diesease Dr. Mulder can be reached at (619) 417-9249 or at gerit.mulder@gmail.com;  gerit.mulder@stvin.org  or on LinkedIn at http://www.linkedin.com/pub/gerit-mulder/a/321/6b5

Buckle up—this episode is coming in hot! As Pfizer continues its slow release of Covid-19 mRNA vaccine study data, we dig into what's been uncovered so far.Today's guest, Sasha Latypova, a former pharmaceutical industry executive with over 20 years in clinical research and regulatory affairs, shares her findings from the first 400 pages released through a FOIA request. Her analysis raises serious concerns, including whether Pfizer ever conducted proper safety testing and the CDC/FDA's claims that the vaccine “stays in the injection site.” Spoiler: The data suggests otherwise. We're linking the full Pfizer documents on our website so you can see the data for yourself!

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Lilly and Novo are leading the pharmaceutical industry with their impressive sales growth of GLP-1 drugs, leaving their competitors in the shadows. Meanwhile, Vir Biotechnology is shifting its focus to immunology following the loss of emergency authorization for its COVID-19 antibody.The shadow market of off-brand versions of GLP-1 drugs is causing regulatory headaches, while Trump's policies continue to impact earnings calls in the pharma sector. Gilead is gearing up for a mid-year launch of lenacapavir, and Novartis has made a major acquisition in a $3.1 billion deal for a blood thinner.In other news, Biogen has secured $250 million from Royalty Pharma for a phase III lupus program, while Lilly is making moves in the mesh and cancer sectors. Inventiva is planning to cut its workforce in half to focus on promising mesh candidates, and Novo executives are working to boost sentiment after a recent error.Stay tuned for more updates in the industry, but remember that job opportunities and other information are always available. For further details, reach out to Annalee Armstrong, senior editor at Biospace. Don't forget to subscribe for a personalized email experience tailored to your preferences.

In this conversation, Dr. Gary Fettke shares his journey from conventional orthopedic surgeon to a prominent advocate for dietary changes in managing diabetes and obesity. He discusses the challenges he faced from regulatory bodies and the food industry while promoting a low-carb, high-fat diet as a solution to the problem of diabetic foot ulcers and metabolic dysfunction more broadly.See Dr Fettke speak live in person at Regenerate Melbourne Summit 2025https://regenerateaus.com/ TIMESTAMPS05:27 The Backlash Against Dietary Changes08:27 The Role of Vested Interests in Medical Guidelines11:34 The Importance of Nutritional Education17:35 The Challenges of Medical Regulation20:43 The Impact of the APRA Process26:40 The Influence of Pharmaceutical Industry on Education29:40 The Role of Red Light Therapy in Healing39:13 Optimizing Metabolic Health39:45 The Role of Mitochondria in Health43:35 Real-World Success Stories in Diabetes Management47:35 Individualized Patient Care vs. Guidelines50:31 The Importance of Questioning in Medicine53:31 Siloing in Medicine and Its Consequences57:25 The Need for Holistic ApproachesFollow DR FETTKEBelinda's website - https://www.nofructose.com/gary-fettke/X - https://x.com/FructoseNoFollow DR MAXWebsite: https://drmaxgulhane.com/Private Group: https://www.skool.com/dr-maxs-circadian-resetCourses: https://drmaxgulhane.com/collections/coursesTwitter: https://twitter.com/MaxGulhaneMDInstagram: https://www.instagram.com/dr_max_gulhane/Apple Podcasts:  https://podcasts.apple.com/podcast/id1661751206Spotify:  https://open.spotify.com/show/6edRmG3IFafTYnwQiJjhwRLinktree: https://linktr.ee/maxgulhanemdDISCLAIMER: The content in this podcast is purely for informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast or YouTube channel.#diabetes #obesity #dietaryguidelines #lowcarb #redlighttherapy #nutritionSend us a textPurchase tickets to Regenerate here - https://regenerateaus.com/ Support the show

In this episode of the Life Science Success Podcast, my guest is David R. Craig, CEO of Sarcomatrix Therapeutics. With over 30 years of experience in the pharmaceutical industry and a track record of successful drug development and commercialization, David brings valuable insights into innovative treatments for muscle wasting diseases.   00:00 Introduction to the Podcast 00:34 Sponsor Message: Bio on the Bayou 2025 02:18 Guest Introduction: David R. Craig, CEO of Sarcomatrix Therapeutics 02:47 David R. Craig's Journey in the Pharmaceutical Industry 06:20 Understanding Muscle Wasting Diseases 08:57 Sarcomatrix's Mission and Innovative Approach 18:14 Challenges in Developing Treatments for Muscle Wasting Diseases 25:42 Balancing Roles and Fundraising Challenges 34:04 Lessons Learned and Inspirations 41:39 Conclusion and Final Thoughts

Dr. Ethan Short, a practicing psychiatrist and host of the Renegade Psych podcast, joins Dr. Roger McFillin for a bold examination of the crisis in American mental healthcare. From the opioid epidemic that devastated his Kentucky hometown to the broader corruption plaguing psychiatric care, Dr. Short exposes how corporate interests and profit motives have transformed mental healthcare into what critics call a "pill mill" system. This candid conversation explores controversial topics including addiction treatment, pharmaceutical industry influence, the suppression of dissenting medical voices, the anti psychiatry movement & systemic barriers toward informed consent.  A must-listen for anyone concerned about the state of mental healthcare in America.00:00 The Mental Health Crisis: An Overview02:39 Challenging the Status Quo in Psychiatry06:36 The Dichotomy of Biological Psychiatry and Anti-Psychiatry10:40 Understanding Severe Mental Illness: A Complex Perspective12:46 The Role of Medication in Mental Health Treatment17:27 The Uncertainty in Mental Health Knowledge20:04 Common Sense Approaches to Mental Well-Being22:55 Natural Remedies vs. Pharmaceutical Solutions29:31 The Historical Context of Bipolar Disorder31:21 The Marketing of Mental Health Diagnoses34:31 The Interplay of Biology and Environment in Mental Health38:16 The Value of Human Emotions39:31 Cultural Perspectives on Suffering40:29 The Role of Perspective in Recovery43:34 Understanding Substance Abuse44:02 The Opioid Epidemic and Personal Impact51:04 Cultural Attitudes Towards Addiction55:54 Navigating Treatment Options58:40 The Spectrum of Addiction Treatment01:10:05 Financial Incentives in Addiction Treatment01:15:18 Individualized Treatment Approaches in Addiction01:18:54 The Role of Community and Support in Recovery01:19:10 Informed Consent and Patient Autonomy01:21:37 Skepticism Towards Medical Authority01:22:32 The Nuances of Vaccination and Public Health01:25:04 Trust Erosion in Medical Institutions01:28:25 Financial Conflicts of Interest in Healthcare01:30:46 Understanding Virus Mutations and Public Perception01:32:52 The Role of Liability in Pharmaceutical Safety01:35:14 Ethics and Informed Consent in Medical Practice01:38:34 The Importance of Nuanced Discussions in MedicineRenegade Psych YoutubeRenegade Psych X AccountRenegad Psych Instagram RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Trump's tariffs are expected to affect the pharmaceutical industry by leading to higher costs and lower margins for companies like J&J, AstraZeneca, Novo Nordisk, and Roche. This could result in financial setbacks for these companies. Meanwhile, GH's inhaled psychedelic has shown success in treating depression, which could provide a new treatment option for patients. In other news, Pfizer's Braftovi has shown promising results in a phase III trial for colorectal cancer, AbbVie's marketing misstep has impacted its aesthetics sales, and Takeda has dropped an epilepsy drug while appointing a new CEO. Overall, the pharmaceutical industry is experiencing various developments and challenges that could impact its future.

Robert Whitaker discusses the failures of psychiatry's disease model and explores alternative approaches to mental health care. Learn about new paradigms for understanding and treating mental health issues. #MentalHealth #PsychiatryReform #AlternativeCare

In this episode, Evonne Brennan joined host Lucy Chard for a chat about the complex world of excipients. Excipients is an ever changing field that involves a lot of moving parts and in the following episode Evonne gave an insight into some of these aspects. The podcast covers the security of the excipient supply chain and how this can influence issues such as drug pricing and drug shortages. Brennan highlights how important communication and collaboration is in this field for education and for pushing to find the next target for progress, that ultimately will make the lives of patients better.

Dr. Hoffman continues his conversation with Dr. Stephen Hussey MS, DC, from MetabolicRevolution.org. 

Guest Dr. Stephen Hussey, a chiropractor and functional medicine practitioner, discusses the importance and impact of a metabolic revolution. Dr. Hussey shares his personal journey of overcoming inflammatory conditions and managing type 1 diabetes through lifestyle changes, focusing on diet and functional medicine principles. The discussion highlights the flaws in conventional medical approaches to chronic diseases and the need for a holistic view of health. Emphasizing the benefits of a low-carb diet and the potential detrimental effects of excessive insulin, the episode explores the benefits of metabolic flexibility. The conversation also introduces the initiative MetabolicRevolution.org, which aims to demand better health guidelines from government agencies, urging a focus on research-based recommendations and reducing industry influence. Dr. Hussey's insights underscore the potential for personal health transformations and advocate for systemic changes to improve public health.

GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download MY BEST SELLING WEIGHT LOSS BOOK: https://www.amazon.com/dp/1570674086?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570674086&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. Moving Medicine Forward Moving Medicine Forward is non-profit that brings the revolutionary practice of disease reversal through plant-based nutrition and lifestyle medicine to medical and allied health professional students across the world. In this series, Drs. Klaper and Burns will share a combined 53 years of insights on dietary approaches to major medical conditions from 'diabesity' to autoimmune disease. They also discuss the 21st century physician's role in protecting the planet and all its inhabitants. You can support Moving Medicine Forward Here: https://www.movingmedforward.com/ Stay Healthy with Dr. Klaper on Instagram: https://www.instagram.com/doctorklape... Check out Dr. Burns' Writing and Blog: https://herbivores.life/

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy. SOURCES:Ezekiel Emanuel, vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine. RESOURCES:"Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal," by Margot Sanger-Katz (The New York Times, 2024)."International Coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches," by Johan L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel (The Lancet, 2024).The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma, by Mustafa Suleyman (2023)."The Significance of Blockbusters in the Pharmaceutical Industry," by Alexander Schuhmacher, Markus Hinder, Nikolaj Boger, Dominik Hartl, and Oliver Gassmann (Nature Reviews Drug Discovery, 2022).Reinventing American Health Care: How the Affordable Care Act Will Improve Our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System, by Ezekiel J. Emanuel (2014)."Why I Hope to Die at 75," by Ezekiel J. Emanuel (The Atlantic, 2014)."Direct-to-Consumer Advertising of Pharmaceuticals," by Ziad F. Gellad and Kenneth W. Lyles (The American Journal of Medicine, 2014).Brothers Emanuel: A Memoir of an American Family, by Ezekiel J. Emanuel (2013)."Bounds in Competing Risks Models and the War on Cancer," by Bo E. Honoré and Adriana Lleras-Muney (Econometrica, 2006). EXTRAS:"How to Fix Medical Research," by People I (Mostly) Admire (2024)."The Suddenly Diplomatic Rahm Emanuel," by Freakonomics Radio (2023)."Ari Emanuel Is Never Indifferent," by Freakonomics Radio (2023)."Who Pays for Multimillion-Dollar Miracle Cures?" by Freakonomics, M.D. (2023)."Who Gets the Ventilator?" by Freakonomics Radio (2020).

Ever stop to think about the real cost of our modern lifestyle? Chronic illness, infertility, rising mental health challenges—they're not accidents. They're symptoms of systems designed to prioritize profit over people and the planet. From ultra-processed foods to toxic farming practices, we're trapped in a cycle that's stealing our vitality. In this episode of Super Life, I sit down with Dr. Zach Bush, a pioneer in regenerative health and farming, to pull back the curtain on how we got here—and how we can change. We're diving into the hidden dangers of our food systems, the power of reconnecting with nature, and practical steps you can take to restore balance to your life (and the planet). Dr. Zach Bush is a triple-board-certified physician specializing in internal medicine and endocrinology, and a globally recognized leader in microbiome research. He's also the founder of Farmer's Footprint, helping farmers transition to regenerative practices that heal our soil and our health. We Also Discuss:    (00:04) Confronting Our Failing Food System (10:00) The Shift: Herbal Medicine to Small Molecules (18:32) Pharmaceuticals, Biodiversity, and the Cost of Progress (46:21) Gender, Infertility, and the Fall of Empires (52:17) Reclaiming Natural Abundance (01:05:40) Humanity's Potential for Transformation   Don't forget… You can order now by heading to darinolien.com/fatal-conveniences-book or order now on Amazon.   Thank You to Our Sponsors Fatty15 : Get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/DARIN and using code DARIN at checkout. Bite: Go to trybite.com/DARIN20 or use code DARIN20 for 20% off your first order. Vivo Barefoot: Get 20% off your first Vivobarefoot order with DARIN20 at www.vivobarefoot.com Keywords: Food System, Healthcare System, Sustainability, Chronic Diseases, Mental Health, Regenerative Farming, Nature's Wisdom, Pharmaceutical Industry, Biodiversity, Virome, Genetic Adaptation, Monoculture, Environmental Change, Generational Trauma, Fertility Crisis, Gender Identity, Economic Empires, Natural Abundance, Human Potential, Transformation, Ancestral Trauma, Personal Growth Find more from Darin: Website: https://darinolien.com/ Instagram: @Darinolien Book: darinolien.com/fatal-conveniences-book/ Down to Earth: darinolien.com/down-to-earth/ Find more from Zach Bush: Website: https://zachbushmd.com/ Instagram: https://www.instagram.com/zachbushmd/

Send us a textIn this eye-opening episode of Healthy & Awake Podcast, Dr. David Healy, a renowned psychiatrist and author of Pharmageddon, exposes how the pharmaceutical industry manipulates doctors and controls medical research. We discuss the hidden dangers of SSRIs, including the increased risk of suicide and homicide, the prevalence of ghostwritten studies, and the influence of Big Pharma on FDA regulations. Dr. Healy explains why adverse drug effects are often dismissed and how the medical propaganda machine has eroded trust between doctors and patients. We also explore the rise of ketamine and psychedelics in depression treatment and the impact of post-SSRI sexual dysfunction (PSSD). Don't miss this critical discussion on why informed consent is crucial and how to navigate the medical system's shortcomings.SSRI's and homicide webinar - https://www.youtube.com/watch?v=fIw3Vnkgng0&t=2sDr. David Healy's Links:https://davidhealy.org/https://rxisk.org/___________________________

Record your first video with Riverside - https://creators.riverside.fm/Codie - and use code CODIE for 15% off an individual plan. Codie Sanchez and Dr. Mike Israetel delve into the complexities of health, fitness, and obesity. They explore the societal and genetic factors contributing to the obesity epidemic, the role of convenience foods, and the impact of medications like Ozempic on appetite and weight management. The discussion also touches on personal responsibility in dietary choices and the cultural perceptions of body image and attraction. This conversation delves into various themes surrounding self-defense for women, the effects of alcohol and cannabis on health, the future of fitness through drugs and genetic enhancements, and the ethical considerations of pharmaceutical companies. The discussion highlights the importance of understanding personal safety, moderation in alcohol consumption, the complexities of cannabis use, and the potential for future advancements in health and fitness through scientific innovations. In this conversation, the speaker delves into various themes surrounding the pharmaceutical industry, corporate responsibility, and the importance of long-term thinking in business. They discuss the competitive nature of the pharmaceutical sector, the alignment of incentives within corporations, and the impact of regulatory environments on economic outcomes. The conversation also touches on the purpose of corporations, teamwork, and the significance of a cooperative mindset in achieving success. Hope you guys enjoy! Checkout More from Codie: Youtube: https://www.youtube.com/@CodieSanchezCT Instagram: https://www.instagram.com/codiesanchez/ TikTok: https://www.tiktok.com/@realcodiesanchez Free newsletter: https://contrarianthinking.biz/3XWLlZp Biz buying course: https://contrarianthinking.biz/3NhjGgN Resibrands: https://resibrands.com/ CT capital: https://contrarianthinking.biz/4eRyGOk Main st hold co: https://contrarianthinking.biz/3YfGa8u

On this episode of the Counter Talk™ Podcast, host Jason Callori speaks with Jerrica Mathis, Vice President of Government Relations, and Bryan Lowe, Director of Government Relations. This episode will explore the perspectives of state and federal government, latest developments in PBM reform and the potential impact of the upcoming election on the pharmaceutical industry. 

This is a free preview of a paid episode. To hear more, visit www.public.newsAll of us rely on the federal government to protect us from industries selling poison. That's why we have thousands of regulations and people working to enforce them.And yet, according to former CBS News investigative reporter, Sharyl Attkison, one industry is not only getting away with poisoning the American people, it's doing so with gigantic taxpayer subsidies: Big Pharma.We should, of course, be grateful for the remarkable drugs available to us and our loved ones. They save millions of lives every year.However, the evidence is overwhelming that the pharmaceutical industry is abusing its power. Its role in creating America's opioid addiction crisis is just the tip of the iceberg. Over the decades, the government has allowed pharmaceutical companies to sell products that either don't work better than a placebo or cause serious harm and death.Now, Attkisson is out with a new book, Follow The Science, that documents the pharmaceutical industry's corruption of government and medical schools.Her book, already a bestseller, comes at a moment of growing alarm about the poor and declining health of the American people.”Chronic diseases have exploded in nature over the past couple of decades without our public health establishment and doctors seeming to notice,” Attkisson told me in a new Public podcast. “Or, if they notice, they're sure not doing anything about it other than throwing pills and treatments at it. We have to understand why the system exists in that way.”

In this episode, Lisa welcomes New York Times best selling author, Dr. Marty Makary. They delve into the medical establishment's handling of health information during the COVID-19 pandemic, focusing on vaccines and chronic diseases. Dr. Makary criticizes the groupthink in medicine and the influence of politics on healthcare, advocating for addressing root causes of chronic diseases through lifestyle changes rather than medications. The conversation also touches on the need for open discussions about vaccines, the impact of processed foods on health, and systemic issues within the pharmaceutical industry. The Truth with Lisa Boothe is part of the Clay Travis & Buck Sexton Podcast Network - new episodes debut every Monday & Thursday.See omnystudio.com/listener for privacy information.

Karen Andersen, biotechnology strategist for Morningstar Research Services, discusses what GLP-1 drugs' demand means for the biopharma industry's five-year outlook. And whether the weight-loss drugs pose a threat to snack food stocks.Why GLP-1 Drugs Are in Demand Competition Between Novo Nordisk and Eli LillyHow Expanding the Conditions GLP-1 Drugs Treats Could Influence Insurance CoverageAre Weight Loss Drugs a Threat to Snack Food Stocks?Big Pharma's Looming Patent CliffHow Medicare Negotiations Impact the Pharmaceutical IndustryWhat is a Biologic Drug?Upcoming Innovations in the Pharmaceutical IndustryWhich BioPharma Drugs Do We Expect to Contract?Big Pharma's Five-Year OutlookBiopharmaceutical Stock Picks Read about topics from this episode. 2024 Biopharmaceutical Industry LandscapeObesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk? Investment Opportunities in the Biopharma Industry Obesity Drug Market: The Next Wave of GLP-1 Competition  What to watch from Morningstar.Is the Fed's Plan to Avoid a Recession Working? Don't Overlook These Crucial Parts of Your Retirement PlanBoating Season Is Over, but Don't Overlook These Recreational Vehicle Stocks5 Ways to Improve America's Retirement Savings Read what our team is writing:Karen Andersen Ivanna Hampton  Follow us on social media.Facebook: https://www.facebook.com/MorningstarInc/X: https://x.com/MorningstarIncInstagram: https://www.instagram.com/morningstar... LinkedIn: https://www.linkedin.com/company/5161/